Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

Gregory Y H Lip, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Francisco Marin, Jurriën M Ten Berg, Karl Georg Haeusler, Giuseppe Boriani, Davide Capodanno, Martine Gilard, Uwe Zeymer, Deirdre Lane, Robert F Storey, Hector Bueno, Jean-Philippe Collet, Laurent Fauchier, Sigrun Halvorsen, Maddalena Lettino, Joao Morais, Christian MuellerTatjana S Potpara, Lars Hvilsted Rasmussen, Andrea Rubboli, Juan Tamargo, Marco Valgimigli, Jose L Zamorano, Document reviewers

Research output: Contribution to journalArticlepeer-review

423 Citations (Scopus)
Original languageEnglish
Pages (from-to)3155-3179
Number of pages25
JournalEuropean Heart Journal
Volume35
Issue number45
Early online date26 Aug 2014
DOIs
Publication statusPublished - 1 Dec 2014

Keywords

  • Acute Coronary Syndrome
  • Administration, Oral
  • Anticoagulants
  • Atrial Fibrillation
  • Cohort Studies
  • Drug Therapy, Combination
  • Fibrinolytic Agents
  • Forecasting
  • Humans
  • Percutaneous Coronary Intervention
  • Perioperative Care
  • Randomized Controlled Trials as Topic
  • Stents
  • Transcatheter Aortic Valve Replacement
  • Treatment Outcome

Cite this